Please use this identifier to cite or link to this item: https://doi.org/10.1042/CS20050085
Title: Towards the application of proteomics in renal disease diagnosis
Authors: Vidal Jr., B.C.
Bonventre, J.V.
I-Hong Hsu, S. 
Keywords: Biomarker
Genomics
Protein expression
Proteomics
Renal disease
Translational research
Issue Date: Nov-2005
Citation: Vidal Jr., B.C., Bonventre, J.V., I-Hong Hsu, S. (2005-11). Towards the application of proteomics in renal disease diagnosis. Clinical Science 109 (5) : 421-430. ScholarBank@NUS Repository. https://doi.org/10.1042/CS20050085
Abstract: Proteomics is widely envisioned as playing a significant role in the translation of genomics to clinically useful applications, especially in the areas of diagnostics and prognostics. In the diagnosis and treatment of kidney disease, a major priority is the identification of disease-associated biomarkers. Proteomics, with its high-throughput and unbiased approach to the analysis of variations in protein expression patterns (actual phenotypic expression of genetic variation), promises to be the most suitable platform for biomarker discovery. Combining such classic analytical techniques as two-dimensional gel electrophoresis with more sophisticated techniques, such as MS, has enabled considerable progress to be made in cataloguing and quantifying proteins present in urine and various kidney tissue compartments in both normal and diseased physiological states. Despite these accomplishments, there remain a number of important challenges that will need to be addressed in order to pave the way for the universal acceptance of proteomics as a clinically relevant diagnostic tool. We discuss issues related to three such critical developmental tasks as follows: (i) completely defining the proteome in the various biological compartments (e.g. tissues, serum and urine) in both health and disease, which presents a major challenge given the dynamic range and complexity of such proteomes; (ii) achieving the routine ability to accurately and reproducibly quantify proteomic expression profiles; and (iii) developing diagnostic platforms that are readily applicable and technically feasible for use in the clinical setting that depend on the fruits of the preceding two tasks to profile multiple disease biomarkers. © 2005 The Biochemical Society.
Source Title: Clinical Science
URI: http://scholarbank.nus.edu.sg/handle/10635/130641
ISSN: 01435221
DOI: 10.1042/CS20050085
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

35
checked on Dec 9, 2018

Page view(s)

7
checked on Dec 14, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.